标题
Deciphering the role of CD47 in cancer immunotherapy
作者
关键词
-
出版物
Journal of Advanced Research
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-28
DOI
10.1016/j.jare.2023.10.009
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker
- (2023) Megan M Dacek et al. BLOOD
- A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety
- (2023) Yulu Li et al. Journal of Hematology & Oncology
- STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
- (2023) Peng Zhang et al. Nature Communications
- Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
- (2023) Yu’e Liu et al. Frontiers in Immunology
- BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
- (2023) Mary J van Helden et al. Journal for ImmunoTherapy of Cancer
- CD47 expression is critical for CAR T-cell survival in vivo
- (2023) Alex N Beckett et al. Journal for ImmunoTherapy of Cancer
- Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
- (2022) Jingjing He et al. CELL RESEARCH
- Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma
- (2022) Miaomiao Li et al. HEMATOLOGICAL ONCOLOGY
- Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity
- (2022) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- Clinical relevance of tumour-associated macrophages
- (2022) Mikael J. Pittet et al. Nature Reviews Clinical Oncology
- Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
- (2022) Nian Jiang et al. Nature Communications
- QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment
- (2022) Kaspar Bresser et al. OncoImmunology
- LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization
- (2022) Jinyang Hu et al. Journal for ImmunoTherapy of Cancer
- SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the “don’t eat me” signal and activating the “eat me” signal
- (2022) Jifeng Yu et al. Journal of Hematology & Oncology
- Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
- (2022) Yoko Nishiga et al. Nature Cancer
- Phase 1 Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
- (2021) Stephen M Ansell et al. CLINICAL CANCER RESEARCH
- RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopenia
- (2021) Bryan Oronsky et al. Expert Opinion on Drug Metabolism & Toxicology
- Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
- (2021) Fangqiu Fu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells
- (2021) Gabriela Andrejeva et al. JOURNAL OF IMMUNOLOGY
- A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC
- (2021) Kaixin Du et al. MOLECULAR THERAPY
- Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
- (2021) Runzhe Shu et al. Molecular Therapy-Oncolytics
- In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit
- (2021) Yusuke Tomita et al. Translational Lung Cancer Research
- METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC
- (2021) Zhuoyang Fan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The multifaceted roles of macrophages in bone regeneration: A story of polarization, activation and time
- (2021) Claudia Schlundt et al. Acta Biomaterialia
- CD47‐Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation In Mouse Liver Inflammation
- (2021) Mingwei Sheng et al. HEPATOLOGY
- Functions of Thrombospondin-1 in the Tumor Microenvironment
- (2021) Sukhbir Kaur et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy
- (2021) Zihao Li et al. LIFE SCIENCES
- LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer
- (2021) Shengjie Xu et al. Cell Death & Disease
- PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer
- (2021) Zhenlin Yang et al. Thoracic Cancer
- RRx-001 Radioprotection: Enhancement of Survival and Hematopoietic Recovery in Gamma-Irradiated Mice
- (2021) Kimberly J. Jurgensen et al. Frontiers in Pharmacology
- Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis
- (2021) Shuai Ren et al. BIOCHEMICAL PHARMACOLOGY
- Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
- (2021) Hao Wu et al. CNS Neuroscience & Therapeutics
- The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
- (2021) Zahra Beizavi et al. MOLECULAR BIOLOGY REPORTS
- Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
- (2021) Rosalynd Upton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual targeting of CTLA-4 and CD47 on Treg cells promotes immunity against solid tumors
- (2021) Anli Zhang et al. Science Translational Medicine
- Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation
- (2021) Zhiqiang Li et al. Translational Oncology
- Regulation of CD47 expression by interferon-gamma in cancer cells
- (2021) Zi-Han Ye et al. Translational Oncology
- Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
- (2021) Mario Orozco-Morales et al. Journal of Immunology Research
- B cells and cancer
- (2021) Victor Engelhard et al. CANCER CELL
- Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment
- (2021) Jie Song et al. JOURNAL OF CONTROLLED RELEASE
- CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
- (2021) Akemi Kosaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
- (2021) Lan Yu et al. Frontiers in Immunology
- SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation
- (2021) Safa Dehmani et al. Frontiers in Immunology
- Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
- (2021) Shih-Hsun Chen et al. Journal for ImmunoTherapy of Cancer
- Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing
- (2021) Dieke J. van Rees et al. Blood Advances
- The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
- (2020) David A Sallman et al. BLOOD
- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor immune microenvironment in head and neck cancers
- (2020) Samantha M. Y. Chen et al. MOLECULAR CARCINOGENESIS
- Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
- (2020) Oscar Arrieta et al. Cancer Medicine
- Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC
- (2020) Annunziata Nigro et al. Frontiers in Immunology
- Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
- (2020) Jennifer Sun et al. Cancers
- Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
- (2020) Mark P. Chao et al. Frontiers in Oncology
- Combination of CD47 and SIRPα constituting the "don't eat me signal" is a prognostic factor in diffuse large B‐cell lymphoma
- (2020) Ryo Kazama et al. CANCER SCIENCE
- The CD47-SIRPα Immune Checkpoint
- (2020) Meike E.W. Logtenberg et al. IMMUNITY
- Single‐cell RNA sequencing study of retinal immune regulators identified CD47 and CD59a expression in photoreceptors—Implications in subretinal immune regulation
- (2020) Jian Liu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
- (2020) Christina A. von Roemeling et al. Nature Communications
- Hypoxia and Macrophages Act in Concert Towards a Beneficial Outcome in Colon Cancer
- (2020) Flávia Martins et al. Cancers
- CD47: the next checkpoint target for cancer immunotherapy
- (2020) Ridong Feng et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells
- (2020) Elena Monti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism
- (2020) Kapil Saxena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T‐cell leukemia/lymphoma
- (2020) Eriko Yanagida et al. HEMATOLOGICAL ONCOLOGY
- Clinicopathological significance of CD47 expression in hepatocellular carcinoma
- (2020) Hyunsung Kim et al. JOURNAL OF CLINICAL PATHOLOGY
- Role of CD47 in Hematological Malignancies
- (2020) Entsar Eladl et al. Journal of Hematology & Oncology
- Neutrophil expressed CD47 regulates CD11b/CD18-dependent neutrophil transepithelial migration in the intestine in vivo
- (2020) Veronica Azcutia et al. Mucosal Immunology
- Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
- (2020) Kaiyue Wu et al. Frontiers in Immunology
- Restoration of miR-340 controls pancreatic cancer cellCD47expression to promote macrophage phagocytosis and enhance antitumor immunity
- (2020) Qing Xi et al. Journal for ImmunoTherapy of Cancer
- CD47 Promotes Age-Associated Deterioration in Angiogenesis, Blood Flow and Glucose Homeostasis
- (2020) Kedar Ghimire et al. Cells
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
- (2020) Reem Saleh et al. CANCER LETTERS
- Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
- (2020) Vanessa Gauttier et al. JOURNAL OF CLINICAL INVESTIGATION
- Profiling of inhibitory immune checkpoints in glioblastoma: Potential pathogenetic players
- (2020) Salvo Lombardo et al. Oncology Letters
- Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
- (2020) Demet Candas-Green et al. Nature Communications
- CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway
- (2020) Yun Liu et al. Frontiers in Oncology
- Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
- (2020) Yan Xu et al. ESMO Open
- Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
- (2020) Harald Herrmann et al. Blood Advances
- The promise of macrophage directed checkpoint inhibitors in myeloid malignancies
- (2020) David M. Swoboda et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
- (2020) Tracy C. Kuo et al. Journal of Hematology & Oncology
- Regulation of CD47 expression in cancer cells
- (2020) Can-Yu Huang et al. Translational Oncology
- Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
- (2020) Jinyang Hu et al. Frontiers in Immunology
- The role of immunotherapy in small cell lung cancer
- (2019) A. Calles et al. Clinical & Translational Oncology
- Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
- (2019) Gregor Hutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- Deciphering the complex role of thrombospondin-1 in glioblastoma development
- (2019) Thomas Daubon et al. Nature Communications
- LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
- (2019) Zi-ming Ye et al. Cell Death & Disease
- Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy
- (2019) Meike E. W. Logtenberg et al. NATURE MEDICINE
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma
- (2019) Shuli Xia et al. CANCER RESEARCH
- Neutrophil plasticity in the tumor microenvironment
- (2019) Morgan Giese et al. BLOOD
- CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies
- (2019) Lijun Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis
- (2019) Zhiqiang Wu et al. CELL RESEARCH
- Noncellular Immune Therapies for Non-Hodgkin Lymphoma
- (2019) Alex F. Herrera HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- HDAC6 Suppresses Let‐7i‐5p to Elicit TSP1/CD47‐mediated Anti‐tumorigenesis and Phagocytosis of Hepatocellular Carcinoma
- (2019) Hee Doo Yang et al. HEPATOLOGY
- miR‐378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47‐SIRPα Axis in Atherosclerosis
- (2019) Wenna Chen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
- (2019) Weiping Li et al. Journal of Hematology & Oncology
- Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
- (2019) Maria Cristina Petralia et al. MOLECULES
- The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
- (2019) C.K. Brierley et al. TRANSFUSION
- Increased lymphocyte activation and atherosclerosis in CD47-deficient mice
- (2019) Daniel Engelbertsen et al. Scientific Reports
- Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment
- (2019) Pulak Ranjan Nath et al. Cancer Immunology Research
- Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
- (2019) Pedro Rodríguez-Jiménez et al. Frontiers in Immunology
- PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts
- (2019) Ana Carolina Martínez-Torres et al. Journal of Oncology
- Targeted Inhibition of CD47-SIRPα Requires Fc-FcγR Interactions to Maximize Activity in T-cell Lymphomas
- (2019) Salvia Jain et al. BLOOD
- CD47 limits autophagy to promote acute kidney injury
- (2019) Maryam El-Rashid et al. FASEB JOURNAL
- Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
- (2019) Sharareh Gholamin et al. Innate Immunity
- CD47: role in the immune system and application to cancer therapy
- (2019) Seyed Mohammad Gheibi Hayat et al. CELLULAR ONCOLOGY
- Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
- (2019) Jing Chen et al. OncoImmunology
- High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting
- (2019) Barbara Mair et al. Nature Biomedical Engineering
- CD47 promotes cell growth and motility in epithelial ovarian cancer
- (2019) Chiu-Lin Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
- (2019) Anthony L. Schwartz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
- (2019) Nasrin Rastgoo et al. HAEMATOLOGICA
- SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
- (2019) Ya-Ping Chen et al. Blood Cancer Journal
- An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease
- (2019) Judite RM Coimbra et al. Future Medicinal Chemistry
- Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding
- (2019) Robyn J. Puro et al. MOLECULAR CANCER THERAPEUTICS
- Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
- (2019) Erik Voets et al. Journal for ImmunoTherapy of Cancer
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
- (2018) Xuyao Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety
- (2018) Xiao-yan Yu et al. BIOCHIMIE
- The MYC oncogene is a global regulator of the immune response
- (2018) Stephanie C. Casey et al. BLOOD
- CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy
- (2018) Yoji Murata et al. CANCER SCIENCE
- Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
- (2018) Xuyao Zhang et al. CARCINOGENESIS
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- Targeting CD47 as a cancer therapeutic strategy
- (2018) Alecia S. Folkes et al. CURRENT OPINION IN ONCOLOGY
- MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
- (2018) Wei Huang et al. Molecular Cancer
- Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia
- (2018) Vanessa Buatois et al. MOLECULAR CANCER THERAPEUTICS
- A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a “Glutamine Trap” To Inhibit Lung Cancer Cell Growth
- (2018) Jiamin Wu et al. MOLECULAR PHARMACEUTICS
- SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis
- (2018) Fei Liu et al. ONCOGENE
- Thrombospondin-1 triggers osteosarcoma cells metastasis and tumor angiogenesis
- (2018) Yue Kui Jian et al. ONCOLOGY RESEARCH
- CD47 promotes human glioblastoma invasion through activation of PI3K/Akt pathway
- (2018) Xuejian Liu et al. ONCOLOGY RESEARCH
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
- (2018) Yismeilin R. Feliz-Mosquea et al. BREAST CANCER RESEARCH AND TREATMENT
- 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T-cell response induced by interleukin-12
- (2018) Marcelo M. Rodríguez et al. MOLECULAR THERAPY
- Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
- (2018) Nayoung Kim et al. Frontiers in Immunology
- Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
- (2018) Yuxin Liu et al. BLOOD REVIEWS
- CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
- (2018) A. Nonino et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells
- (2018) Ashanti Concepción Uscanga‐Palomeque et al. CANCER SCIENCE
- The Macrophage in Cardiac Homeostasis and Disease
- (2018) Kory J. Lavine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
- (2018) Eric Hatterer et al. mAbs
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia
- (2018) Kun Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury
- (2018) Jeffrey S. Isenberg et al. PEDIATRIC NEPHROLOGY
- Monoclonal anti-CD47 interference in red cell and platelet testing
- (2018) Randall W. Velliquette et al. TRANSFUSION
- Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice
- (2018) Yu Hu et al. Transplant Infectious Disease
- Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs
- (2018) Adeline N. Boettcher et al. XENOTRANSPLANTATION
- CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
- (2018) Pulak Ranjan Nath et al. Frontiers in Immunology
- Anticancer effects of anti-CD47 immunotherapy in vivo
- (2018) Kristina Iribarren et al. OncoImmunology
- Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
- (2018) Kulthida Vaeteewoottacharn et al. Translational Oncology
- Nonapoptotic functions of Fas/CD95 in the immune response
- (2017) Jean-Philippe Guégan et al. FEBS Journal
- Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
- (2017) Meng Michelle Xu et al. IMMUNITY
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses
- (2017) Boning Liu et al. mAbs
- CD47 limits antibody dependent phagocytosis against non-malignant B cells
- (2017) Sandra Gallagher et al. MOLECULAR IMMUNOLOGY
- Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
- (2017) Elie Dheilly et al. MOLECULAR THERAPY
- SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
- (2017) Jun Chen et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SIRPα+dendritic cells regulate homeostasis of fibroblastic reticular cells via TNF receptor ligands in the adult spleen
- (2017) Yasuyuki Saito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- Post-translational Control of Intracellular Pathogen Sensing Pathways
- (2017) Cindy Chiang et al. TRENDS IN IMMUNOLOGY
- A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
- (2017) Paola A. Betancur et al. Nature Communications
- MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
- (2017) Cong Lv et al. Nature Communications
- Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
- (2017) E C Pietsch et al. Blood Cancer Journal
- Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer
- (2017) Zhang Xiping et al. Oncotarget
- Rational Combination Immunotherapy: Understand the Biology
- (2017) Howard L. Kaufman Cancer Immunology Research
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
- (2017) Xuyao Zhang et al. Cancer Immunology Research
- Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
- (2017) Feng Li et al. OncoImmunology
- Aberrant Reduction of MiR-141 Increased CD47/CUL3 in Hirschsprung's Disease
- (2017) Weibing Tang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Inhibitory effect of flavonoids on human glutaminyl cyclase
- (2016) Manman Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SIRP -Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
- (2016) E. C. Piccione et al. CLINICAL CANCER RESEARCH
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells
- (2016) Zhen Bian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Durable antitumor responses to CD47 blockade require adaptive immune stimulation
- (2016) Jonathan T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
- (2016) Akanksha Chhabra et al. Science Translational Medicine
- Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
- (2016) Nara Lee et al. YONSEI MEDICAL JOURNAL
- Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
- (2016) Qi Gao et al. Cell Death & Disease
- A fully human anti-CD47 blocking antibody with therapeutic potential for cancer
- (2016) Dadi Zeng et al. Oncotarget
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
- (2015) Jessica Lo et al. HEPATOLOGY
- CD47 blockade as another immune checkpoint therapy for cancer
- (2015) Robert H Vonderheide NATURE MEDICINE
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk
- (2015) Mingye Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
- (2015) Seung Yeob Yang et al. Oncotarget
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Cutting Edge: CD47 Controls the In Vivo Proliferation and Homeostasis of Peripheral CD4+CD25+Foxp3+ Regulatory T Cells That Express CD103
- (2014) V. Q. Van et al. JOURNAL OF IMMUNOLOGY
- CD47 Expression on T Cell Is a Self-Control Negative Regulator of Type 1 Immune Response
- (2014) S. Bouguermouh et al. JOURNAL OF IMMUNOLOGY
- Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway
- (2013) Yanzhang Li et al. Cellular & Molecular Immunology
- MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α
- (2013) Dihan Zhu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tissue-resident macrophages
- (2013) Luke C Davies et al. NATURE IMMUNOLOGY
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- The lysosome: from waste bag to potential therapeutic target
- (2013) Hanna Appelqvist et al. Journal of Molecular Cell Biology
- Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors
- (2013) Sukhbir Kaur et al. Scientific Reports
- CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
- (2012) SHIGEMASA SUZUKI et al. ONCOLOGY REPORTS
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
- (2011) M. P. Chao et al. BLOOD
- The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
- (2011) Holger Cynis et al. EMBO Molecular Medicine
- Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1
- (2011) Sukhbir Kaur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thrombospondin-1: Multiple Paths to Inflammation
- (2011) Zenaida Lopez-Dee et al. MEDIATORS OF INFLAMMATION
- Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
- (2010) Mark P. Chao et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway
- (2010) Emilie Sick et al. GLIA
- Integrin-Induced PIP5K1C Kinase Polarization Regulates Neutrophil Polarization, Directionality, and In Vivo Infiltration
- (2010) Wenwen Xu et al. IMMUNITY
- Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47
- (2010) Sukhbir Kaur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein posttranslational modifications: Chemistry, biology, and applications
- (2010) Hening Lin et al. Molecular BioSystems
- Post-translational modifications in signal integration
- (2010) Yonathan Lissanu Deribe et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
- (2009) Andreas Junker et al. BRAIN
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Neurovascular effects of CD47 signaling: Promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro
- (2009) Changhong Xing et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
- (2009) Takashi Matozaki et al. TRENDS IN CELL BIOLOGY
- Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system
- (2008) S. Kusakari et al. JOURNAL OF CELL SCIENCE
- Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47
- (2008) Deborah Hatherley et al. MOLECULAR CELL
- Association of CD47 with Natural Killer Cell-Mediated Cytotoxicity of Head-and-Neck Squamous Cell Carcinoma Lines
- (2008) Min Jung Kim et al. TUMOR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now